244 related articles for article (PubMed ID: 8196656)
1. Apoptosis in erythroid progenitors deprived of erythropoietin occurs during the G1 and S phases of the cell cycle without growth arrest or stabilization of wild-type p53.
Kelley LL; Green WF; Hicks GG; Bondurant MC; Koury MJ; Ruley HE
Mol Cell Biol; 1994 Jun; 14(6):4183-92. PubMed ID: 8196656
[TBL] [Abstract][Full Text] [Related]
2. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
[TBL] [Abstract][Full Text] [Related]
3. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production.
Kelley LL; Koury MJ; Bondurant MC; Koury ST; Sawyer ST; Wickrema A
Blood; 1993 Oct; 82(8):2340-52. PubMed ID: 8400286
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis and cell cycle-specific change in expression of p53 in normal lymphocytes and MOLT-4 leukemic cells by nitrogen mustard.
Bhatia U; Danishefsky K; Traganos F; Darzynkiewicz Z
Clin Cancer Res; 1995 Aug; 1(8):873-80. PubMed ID: 9816057
[TBL] [Abstract][Full Text] [Related]
5. Increased erythropoietin sensitivity after in vitro transformation of hematopoietic precursors by RNA tumor viruses.
Hankins WD
J Natl Cancer Inst; 1983 Apr; 70(4):725-34. PubMed ID: 6572760
[TBL] [Abstract][Full Text] [Related]
6. Distinct p53-mediated G1/S checkpoint responses in two NIH3T3 subclone cells following treatment with DNA-damaging agents.
Huang TS; Kuo ML; Shew JY; Chou YW; Yang WK
Oncogene; 1996 Aug; 13(3):625-32. PubMed ID: 8760304
[TBL] [Abstract][Full Text] [Related]
7. Regulation of p53-mediated apoptosis and cell cycle arrest by Steel factor.
Abrahamson JL; Lee JM; Bernstein A
Mol Cell Biol; 1995 Dec; 15(12):6953-60. PubMed ID: 8524262
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin-induced cellular differentiation requires prolongation of the G1 phase of the cell cycle.
Carroll M; Zhu Y; D'Andrea AD
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2869-73. PubMed ID: 7708739
[TBL] [Abstract][Full Text] [Related]
9. Mode of action of erythropoietin (Epo) in an Epo-dependent murine cell line. II. Cell cycle dependency of Epo action.
Tsuda H; Sawada T; Kawakita M; Takatsuki K
Exp Hematol; 1989 Mar; 17(3):218-22. PubMed ID: 2917620
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of G1 checkpoint function by the non-genotoxic carcinogen phenobarbital.
Gonzales AJ; Christensen JG; Preston RJ; Goldsworthy TL; Tlsty TD; Fox TR
Carcinogenesis; 1998 Jul; 19(7):1173-83. PubMed ID: 9683175
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin-specific cell cycle progression in erythroid subclones of the interleukin-3-dependent cell line 32D.
Shimada Y; Migliaccio G; Ralph H; Migliaccio AR
Blood; 1993 Feb; 81(4):935-41. PubMed ID: 7679009
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis and hematopoiesis in murine fetal liver.
Yu H; Bauer B; Lipke GK; Phillips RL; Van Zant G
Blood; 1993 Jan; 81(2):373-84. PubMed ID: 7678514
[TBL] [Abstract][Full Text] [Related]
13. Regulation of programmed death in erythroid progenitor cells by erythropoietin: effects of calcium and of protein and RNA syntheses.
Kelley LL; Koury MJ; Bondurant MC
J Cell Physiol; 1992 Jun; 151(3):487-96. PubMed ID: 1284250
[TBL] [Abstract][Full Text] [Related]
14. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
15. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts.
Di Leonardo A; Linke SP; Clarkin K; Wahl GM
Genes Dev; 1994 Nov; 8(21):2540-51. PubMed ID: 7958916
[TBL] [Abstract][Full Text] [Related]
16. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
[TBL] [Abstract][Full Text] [Related]
17. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells.
Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ
J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861
[TBL] [Abstract][Full Text] [Related]
18. Murine pluripotent hematopoietic progenitors constitutively expressing a normal erythropoietin receptor proliferate in response to erythropoietin without preferential erythroid cell differentiation.
Dubart A; Feger F; Lacout C; Goncalves F; Vainchenker W; Dumenil D
Mol Cell Biol; 1994 Jul; 14(7):4834-42. PubMed ID: 8007982
[TBL] [Abstract][Full Text] [Related]
19. DNA damage and p53-mediated cell cycle arrest: a reevaluation.
Pellegata NS; Antoniono RJ; Redpath JL; Stanbridge EJ
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15209-14. PubMed ID: 8986789
[TBL] [Abstract][Full Text] [Related]
20. Activation of apoptosis associated with enforced myc expression in myeloid progenitor cells is dominant to the suppression of apoptosis by interleukin-3 or erythropoietin.
Askew DS; Ihle JN; Cleveland JL
Blood; 1993 Oct; 82(7):2079-87. PubMed ID: 8400257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
